new cancer drug, Glivec

There's a lot of excitement about the new cancer drug, Glivec.

Novartis is marketing it now in the U.S., but under the brand name Gleevec. The drug company is still deciding whether to call it Gleevec or Glivec when it becomes available in Canada later.

Glivec (imatinib) is effective for treating chronic myeloid leukemia (CML) it might also be useful for treating other forms of cancer.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote